92 related articles for article (PubMed ID: 26214410)
1. Wnt1-induced MAFK expression promotes osteosarcoma cell proliferation.
Wang R; Zheng J; Zhang DS; Yang YH; Zhao ZF
Genet Mol Res; 2015 Jul; 14(3):7315-25. PubMed ID: 26214410
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA Sox4 promotes proliferation and migration by activating Wnt/β-catenin signaling pathway in osteosarcoma.
Tian Z; Yang G; Jiang P; Zhang L; Wang J; Sun S
Pharmazie; 2017 Sep; 72(9):537-542. PubMed ID: 29441981
[TBL] [Abstract][Full Text] [Related]
5. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/β-catenin signaling pathway.
Wang Y; Sun S; Xu J; Luo Y; Xin Y; Zhao X
Oncol Rep; 2018 Feb; 39(2):589-596. PubMed ID: 29207112
[TBL] [Abstract][Full Text] [Related]
7. Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.
Liu H; Chen Y; Zhou F; Jie L; Pu L; Ju J; Li F; Dai Z; Wang X; Zhou S
Int J Clin Exp Pathol; 2014; 7(8):4795-805. PubMed ID: 25197350
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
[TBL] [Abstract][Full Text] [Related]
9. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
Du X; Yang J; Yang D; Tian W; Zhu Z
BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
11. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of NKD1 in human osteosarcoma and its clinical significance.
Chen X; Xu P; Zhu J; Liu F
Mol Med Rep; 2018 Jan; 17(1):1111-1117. PubMed ID: 29115501
[TBL] [Abstract][Full Text] [Related]
13. Peroxiredoxin 1 (PRDX1) Suppresses Progressions and Metastasis of Osteosarcoma and Fibrosarcoma of Bone.
Wang Y; Liu M; Yang P; Peng H
Med Sci Monit; 2018 Jun; 24():4113-4120. PubMed ID: 29908016
[TBL] [Abstract][Full Text] [Related]
14. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
Xie XK; Yang DS; Ye ZM; Tao HM
Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
[TBL] [Abstract][Full Text] [Related]
15. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway.
Liu X; Li L; Lv L; Chen D; Shen L; Xie Z
Oncol Rep; 2015 Aug; 34(2):1035-41. PubMed ID: 26035210
[TBL] [Abstract][Full Text] [Related]
16. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
17. Wnt pathway in osteosarcoma, from oncogenic to therapeutic.
Cai Y; Cai T; Chen Y
J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin.
Xu WG; Shang YL; Cong XR; Bian X; Yuan Z
Int J Oncol; 2014 Nov; 45(5):2024-32. PubMed ID: 25190111
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway.
Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y
Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]